Multiplex Assay Kit for Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay)

LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-95 82
EDTA plasma(n=5) 84-98 94
heparin plasma(n=5) 80-101 83

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-101% 85-103% 99-105% 78-102%
EDTA plasma(n=5) 95-103% 88-102% 79-93% 93-105%
heparin plasma(n=5) 97-105% 78-103% 86-103% 85-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:LOXL2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
BMC Cancer. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 Pubmed: 24007603
Current Eye Research High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells Pubmed: 22966818
Curr Eye Res Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation Pubmed:27116380
BMC Cancer Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study Pubmed:29558905
Laryngoscope Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma Pubmed: 31219623
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPF552Ra02 Recombinant Lysyl Oxidase Like Protein 2 (LOXL2) Positive Control; Immunogen; SDS-PAGE; WB.
RPF552Ra01 Recombinant Lysyl Oxidase Like Protein 2 (LOXL2) Positive Control; Immunogen; SDS-PAGE; WB.
PAF552Ra02 Polyclonal Antibody to Lysyl Oxidase Like Protein 2 (LOXL2) WB; IHC; ICC; IP.
PAF552Ra01 Polyclonal Antibody to Lysyl Oxidase Like Protein 2 (LOXL2) WB; IHC; ICC; IP.
LAF552Ra81 FITC-Linked Polyclonal Antibody to Lysyl Oxidase Like Protein 2 (LOXL2) WB; IHC; ICC; IF.
LAF552Ra71 Biotin-Linked Polyclonal Antibody to Lysyl Oxidase Like Protein 2 (LOXL2) WB; IHC; ICC.
SEF552Ra ELISA Kit for Lysyl Oxidase Like Protein 2 (LOXL2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF552Ra Multiplex Assay Kit for Lysyl Oxidase Like Protein 2 (LOXL2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.